Clinical Trials · NCT07204249
Glutide for Ending Methamphetamine
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- San Francisco Department of Public Health
- Enrollment
- 162
- Start date
- Feb 2026
- Locations
- 1 site, United States
- Primary endpoint
- Ratio of eligible to enrolled participants